Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of MXN 2.67 trillion. The enterprise value is 3.59 trillion.

Market Cap	2.67T
Enterprise Value	3.59T

Important Dates

The last earnings date was Tuesday, August 5, 2025.

Earnings Date	Aug 5, 2025
Ex-Dividend Date	Jul 25, 2025

Share Statistics

Current Share Class	5.69B
Shares Outstanding	n/a
Shares Change (YoY)	+0.92%
Shares Change (QoQ)	-0.07%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 13.19 and the forward PE ratio is 9.03.

PE Ratio	13.19
Forward PE	9.03
PS Ratio	2.22
PB Ratio	1.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.43, with an EV/FCF ratio of 15.32.

EV / Earnings	17.72
EV / Sales	3.01
EV / EBITDA	7.43
EV / EBIT	10.74
EV / FCF	15.32

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.70.

Current Ratio	1.16
Quick Ratio	0.78
Debt / Equity	0.70
Debt / EBITDA	2.42
Debt / FCF	4.99
Interest Coverage	6.26

Financial Efficiency

Return on equity (ROE) is 12.17% and return on invested capital (ROIC) is 7.18%.

Return on Equity (ROE)	12.17%
Return on Assets (ROA)	5.25%
Return on Invested Capital (ROIC)	7.18%
Return on Capital Employed (ROCE)	10.53%
Revenue Per Employee	14.85M
Profits Per Employee	2.50M
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.45

Taxes

Income Tax	-4.43B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.32% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-13.32%
50-Day Moving Average	462.05
200-Day Moving Average	497.48
Relative Strength Index (RSI)	57.63
Average Volume (20 Days)	44,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.63

Income Statement

In the last 12 months, Pfizer had revenue of MXN 1.20 trillion and earned 202.66 billion in profits. Earnings per share was 35.70.

Revenue	1.20T
Gross Profit	888.16B
Operating Income	334.28B
Pretax Income	198.53B
Net Income	202.66B
EBITDA	461.90B
EBIT	334.28B
Earnings Per Share (EPS)	35.70

Full Income Statement

Balance Sheet

The company has 249.72 billion in cash and 1.17 trillion in debt, giving a net cash position of -919.71 billion.

Cash & Cash Equivalents	249.72B
Total Debt	1.17T
Net Cash	-919.71B
Net Cash Per Share	n/a
Equity (Book Value)	1.68T
Book Value Per Share	294.07
Working Capital	112.66B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 286.27 billion and capital expenditures -51.83 billion, giving a free cash flow of 234.44 billion.

Operating Cash Flow	286.27B
Capital Expenditures	-51.83B
Free Cash Flow	234.44B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 73.82%, with operating and profit margins of 27.78% and 16.84%.

Gross Margin	73.82%
Operating Margin	27.78%
Pretax Margin	16.50%
Profit Margin	16.84%
EBITDA Margin	38.39%
EBIT Margin	27.78%
FCF Margin	19.49%

Dividends & Yields

This stock pays an annual dividend of 33.53, which amounts to a dividend yield of 7.10%.

Dividend Per Share	33.53
Dividend Yield	7.10%
Dividend Growth (YoY)	14.82%
Years of Dividend Growth	1
Payout Ratio	89.68%
Buyback Yield	-0.92%
Shareholder Yield	6.18%
Earnings Yield	7.58%
FCF Yield	8.77%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.2 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.2
Piotroski F-Score	8